Emergency and elective cardiac retransplantation

Authors:
  • MRM Rinaldi
    M Rinaldi
  • CGC Goggi
    C Goggi
  • CPC Pederzolli
    C Pederzolli
  • ADA Darmini
    A Darmini
  • NPN Pederzolli
    N Pederzolli
  • MVM Vigano
    M Vigano

Abstract
Among 265 patients transplanted at our Institution, 7 underwent cardiacretransplantation. There were five emergency retransplantations, theindication being graft failure in one case and acute rejection in fourcases. Two patients, retransplanted because of acute rejection, had apositive panel reactivity antibody and a negative donor crossmatch. In therejection cases immunosuppression was enhanced by perioperativeplasmapheresis and a postoperative 1-month course of cyclophosphamide. Intwo cases emergency retransplantations were successfully performed despitea highly positive prospective crossmatch. Two patients underwent electiveretransplantations for chronic rejection 12 and 41 months, respectively,after the primary transplants. The overall early and late survival ratesare 71% and 57%, respectively, with a mean follow-up of 48.5 months. Theearly and late mortality for elective retransplantation is zero. Ourexperience confirms both the high operative risk for emergencyretransplantation and the excellent results for elective retransplantation.The use of plasmapheresis and cyclophosphamide allowed us to undertakeretransplantation successfully in 2 cases with positive donor crossmatch.Both hyperimmunized patients in our series were retransplanted because ofirreversible acute rejection despite a negative crossmatch with the primarydonor. The meaning of negative crossmatch in patients with preformedcytotoxic antibodies is therefore questionable.